Co-designing care for multimorbidity: a systematic review.

Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2003-

Multimorbidity* ; Quality of Life*; Humans ; Outcome Assessment, Health Care

Background: The co-design of health care enables patient-centredness by partnering patients, clinicians and other stakeholders together to create services.
Methods: We conducted a systematic review of co-designed health interventions for people living with multimorbidity and assessed (a) their effectiveness in improving health outcomes, (b) the co-design approaches used and (c) barriers and facilitators to the co-design process with people living with multimorbidity. We searched MEDLINE, EMBASE, CINAHL, Scopus and PsycINFO between 2000 and March 2022. Included experimental studies were quality assessed using the Cochrane risk of bias tool (ROB-2 and ROBINS-I).
Results: We screened 14,376 reports, with 13 reports meeting the eligibility criteria. Two reported health and well-being outcomes: one randomised clinical trial (n = 134) and one controlled cohort (n = 1933). Outcome measures included quality of life, self-efficacy, well-being, anxiety, depression, functional status, healthcare utilisation and mortality. Outcomes favouring the co-design interventions compared to control were minimal, with only 4 of 17 outcomes considered beneficial. Co-design approaches included needs assessment/ideation (12 of 13), prototype (11 of 13), pilot testing (5 of 13) (i.e. focus on usability) and health and well-being evaluations (2 of 13). Common challenges to the co-design process include poor stakeholder interest, passive participation, power imbalances and a lack of representativeness in the design group. Enablers include flexibility in approach, smaller group work, advocating for stakeholders' views and commitment to the process or decisions made.
Conclusions: In this systematic review of co-design health interventions, we found that few projects assessed health and well-being outcomes, and the observed health and well-being benefits were minimal. The intensity and variability in the co-design approaches were substantial, and challenges were evident. Co-design aided the design of novel services and interventions for those with multimorbidity, improving their relevance, usability and acceptability. However, the clinical benefits of co-designed interventions for those with multimorbidity are unclear.
(© 2024. The Author(s).)

Age Ageing. 2016 Sep;45(5):643-51. (PMID: 27298381)
Aust J Rural Health. 2020 Apr;28(2):149-158. (PMID: 31970832)
J Multimorb Comorb. 2022 Oct 27;12:26335565221134017. (PMID: 36325259)
Int J Environ Res Public Health. 2018 Jun 05;15(6):. (PMID: 29874883)
Nephrology (Carlton). 2018 Aug;23(8):711-717. (PMID: 29405503)
BMC Nurs. 2020 Feb 04;19:9. (PMID: 32042264)
Int J Environ Res Public Health. 2021 Dec 30;19(1):. (PMID: 35010652)
Cochrane Database Syst Rev. 2021 Jan 15;1:CD006560. (PMID: 33448337)
Patient. 2014;7(4):387-95. (PMID: 25034612)
JBI Database System Rev Implement Rep. 2019 Jan;17(1):3-9. (PMID: 30024434)
Fam Pract. 2022 Jul 19;39(4):592-602. (PMID: 34546341)
Int J Integr Care. 2021 Apr 30;21(2):16. (PMID: 33981193)
Health Expect. 2018 Apr;21(2):448-456. (PMID: 29139220)
Qual Saf Health Care. 2006 Oct;15(5):307-10. (PMID: 17074863)
J Med Internet Res. 2020 Jun 15;22(6):e15449. (PMID: 32538793)
J Med Internet Res. 2020 Aug 13;22(8):e18476. (PMID: 32788144)
J Med Internet Res. 2019 May 30;21(5):e12996. (PMID: 31148545)
BMJ Qual Saf. 2020 Jan;29(1):64-76. (PMID: 31548278)
Aust Health Rev. 2021 Aug;45(4):472-484. (PMID: 33588988)
Health Expect. 2018 Apr;21(2):539-548. (PMID: 29266797)
Int J Environ Res Public Health. 2017 Nov 29;14(12):. (PMID: 29186055)
J Patient Exp. 2020 Oct;7(5):688-696. (PMID: 33294602)
BMJ. 2016 Oct 12;355:i4919. (PMID: 27733354)
Patient. 2020 Dec;13(6):757-766. (PMID: 33083997)
J Am Med Inform Assoc. 2017 Sep 01;24(5):927-932. (PMID: 28371853)
Gerontologist. 2021 Sep 13;61(7):e395-e409. (PMID: 32506136)
BMJ. 2019 Aug 28;366:l4898. (PMID: 31462531)
Int J Lang Commun Disord. 2021 Jan;56(1):90-101. (PMID: 33325623)
J Appl Res Intellect Disabil. 2018 Sep;31(5):669-686. (PMID: 29231285)
Stud Health Technol Inform. 2020 Jun 16;270:1423-1424. (PMID: 32570690)
Ann Fam Med. 2018 Mar;16(2):132-138. (PMID: 29531104)
Health Res Policy Syst. 2020 Feb 11;18(1):17. (PMID: 32046728)
JMIR Hum Factors. 2021 Jan 13;8(1):e18587. (PMID: 33439146)
Health Technol Assess. 2004 Apr;8(15):1-148, III-IV. (PMID: 15080866)
BMJ Open. 2019 Aug 15;9(8):e030385. (PMID: 31420396)
Front Med (Lausanne). 2022 Feb 24;9:815783. (PMID: 35280865)
Implement Sci. 2018 Jul 26;13(1):98. (PMID: 30045735)
PLoS One. 2017 May 5;12(5):e0177102. (PMID: 28475606)
BMC Med. 2016 Jun 22;14(1):88. (PMID: 27328975)
BMC Fam Pract. 2015 Oct 14;16:129. (PMID: 26462820)
BMJ Open. 2017 Jul 11;7(7):e014650. (PMID: 28701409)
Clinicoecon Outcomes Res. 2023 May 17;15:333-347. (PMID: 37220481)

Keywords: Chronic disease; Co-design; Multimorbidity; Systematic review

Date Created: 20240206 Date Completed: 20240208 Latest Revision: 20240212

20240212

PMC10848537

10.1186/s12916-024-03263-9

38321495